X-18507092-T-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2

The NM_001323289.2(CDKL5):​c.-5T>A variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0000922 in 1,182,821 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 25 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.000084 ( 0 hom. 19 hem. )

Consequence

CDKL5
NM_001323289.2 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 4.73

Publications

1 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
CDKL5 Gene-Disease associations (from GenCC):
  • CDKL5 disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • precocious puberty
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BP6
Variant X-18507092-T-A is Benign according to our data. Variant chrX-18507092-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 379694.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00017 (19/111623) while in subpopulation EAS AF = 0.00505 (18/3561). AF 95% confidence interval is 0.00327. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 19 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKL5NM_001323289.2 linkc.-5T>A 5_prime_UTR_variant Exon 2 of 18 ENST00000623535.2 NP_001310218.1 O76039-2
CDKL5NM_001037343.2 linkc.-5T>A 5_prime_UTR_variant Exon 3 of 22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.-5T>A 5_prime_UTR_variant Exon 2 of 21 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkc.-5T>A 5_prime_UTR_variant Exon 2 of 18 1 NM_001323289.2 ENSP00000485244.1 O76039-2

Frequencies

GnomAD3 genomes
AF:
0.000170
AC:
19
AN:
111571
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00504
Gnomad SAS
AF:
0.000375
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000382
AC:
70
AN:
183202
AF XY:
0.000340
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00491
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000443
GnomAD4 exome
AF:
0.0000840
AC:
90
AN:
1071198
Hom.:
0
Cov.:
25
AF XY:
0.0000558
AC XY:
19
AN XY:
340290
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25927
American (AMR)
AF:
0.00
AC:
0
AN:
35164
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19189
East Asian (EAS)
AF:
0.00256
AC:
77
AN:
30061
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53464
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40506
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4072
European-Non Finnish (NFE)
AF:
0.00000856
AC:
7
AN:
817602
Other (OTH)
AF:
0.000133
AC:
6
AN:
45213
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000170
AC:
19
AN:
111623
Hom.:
0
Cov.:
23
AF XY:
0.000177
AC XY:
6
AN XY:
33805
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30756
American (AMR)
AF:
0.00
AC:
0
AN:
10405
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2656
East Asian (EAS)
AF:
0.00505
AC:
18
AN:
3561
South Asian (SAS)
AF:
0.000376
AC:
1
AN:
2660
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5984
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53186
Other (OTH)
AF:
0.00
AC:
0
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.537
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.000193

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 28, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

CDKL5-related disorder Benign:1
Apr 18, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.25
CADD
Benign
19
DANN
Benign
0.93
PhyloP100
4.7
Mutation Taster
=300/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79219416; hg19: chrX-18525212; API